title: Clinical pearls in infectious diseases.
authors.affiliation: Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905, USA. orenstein.robert@mayo.edu
authors.forename: Robert
authors.initials: R
authors.lastname: Orenstein
authors.forename: Scott C
authors.initials: SC
authors.lastname: Litin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D005260:Female; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D018579:Patient Selection; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy; D016585:Vaginosis, Bacterial / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007052:Ibuprofen